Results 11 to 20 of about 2,423,192 (204)
Dynamic vascular changes in chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy [PDF]
Residual pulmonary hypertension is an important sequela after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Recurrent thrombosis or embolism could be a contributor to this residual pulmonary hypertension but the potential ...
Dieuwertje Ruigrok +10 more
doaj +2 more sources
Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension
OBJECTIVES: Chronic thromboembolic pulmonary hypertension is one of the most prevalent forms of pulmonary hypertension and is a major complication of acute pulmonary embolism.
Francisca Alexandra Gavilanes-Oleas +9 more
doaj +2 more sources
Chronic thromboembolic pulmonary hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially fatal disease, which may occur as a rare complication after acute pulmonary embolism, although the exact epidemiology of CTEPH is unknown.
Isabelle Opitz, Silvia Ulrich
doaj +2 more sources
Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism [PDF]
Background Chronic thromboembolic pulmonary hypertension after pulmonary embolism is associated with high morbidity and mortality. Understanding the incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism is important for ...
Frederikus A. Klok +5 more
doaj +3 more sources
Pulmonary arteriovenous malformation in chronic thromboembolic pulmonary hypertension
Chronic thromboembolic pulmonary hypertension is a morbid condition associated with complications such as hemoptysis, right heart failure, paradoxical embolism, and even death.
Arun Sharma +3 more
doaj +2 more sources
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at light activity and general fatigue that limits daily activities.
Barbro Kjellström +4 more
doaj +1 more source
Background: Antiphospholipid syndrome is an autoimmune disease characterized by the occurrence of venous and/or arterial thrombosis. Chronic thromboembolism is one of the known established pathogenesis of pulmonary hypertension, known as chronic ...
Serpil Taş +12 more
doaj +1 more source
Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease. [PDF]
BACKGROUND: Morbidity in COPD results from a combination of factors including hypoxia-induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal studies suggest a role of angiotensin II and acute studies in man concur.
Shakur, B Haleema +17 more
core +2 more sources
Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH ...
core +1 more source
To the editor, In response to: Assessment of oxygenation after balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. We read with interest the study by Matsuoka et al.
Morris, Norman R +4 more
core +1 more source

